CD68 and myeloid sarcoma: To determine the contribution of distinct immune cell types on remyelination in MS, we next analyzed the abundance of CD68+ macrophages/microglia, CD3+ T cells, and CD20+ B cells in active MS lesions since this lesion type is prone to remyelination [53].